Clinical Trial Update: Neurobiology of Bulimia Nervosa [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the neurobiology of bulimia nervosa; completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bulimia Nervosa

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Bulimia Nervosa | Phase 2 | Status: COMPLETED | Results posted: 2022-07-26